In response to COVID-19, GHX is committed to helping ensure that our customers receive access to the data and information needed to help maintain critical supplies to serve patients and protect staff. Click to learn more
Log In

From Harvard Business Review, October 31, 2018

By Scott Falk, MD, Director of Performance Improvement, Quality and Safety; and Associate Professor of Anesthesiology and Critical Care, Penn Medicine (University of Pennsylvania Health System), Physician Advisor, Lumere; John Cherf, MD, MPH, MBA, Chief of Orthopedic Surgery, Advocate Illinois Masonic Medical Center (Advocate Aurora Health) and Chief Medical Officer, Lumere; and Julie Schulz, MD, MPH, Physician Advisor, Lumere

We recently conducted an in-depth study at Lumere to gain insight into physicians’ perceptions of clinical variation and the factors influencing their choices of drugs and devices. Based on a survey of 276 physicians, our study results show that it’s necessary to consistently and frequently share cost data and clinical evidence with physicians, regardless of whether they’re affiliated with or directly employed by a hospital. This empowers physicians to support the quality and cost goals inherent in a health system’s value-based care model. Below, we offer three recommendations for health systems looking to do this.

Read the full article in Harvard Business Review.

More News